ACT Capital Management, LLC is an SEC-registered investment adviser based in Wayne, PA that reports managing 5 hedge funds on Form ADV. It reports $163.9 million in regulatory assets under management. Its private funds, of all types, hold $148.4 million in gross assets. Its disclosed U.S. stock holdings returned an estimated +21.8% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +21.8% from Q1 2026 to Q2 2026, compared with +9.5% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- $163.9 millionForm ADV Item 5.F
- Gross assets of private funds
- $148.4 millionAll private fund types, Form ADV
- Hedge funds managed
- 55 private funds in total
- Employees
- 2Form ADV Item 5.A
- Registration
- SEC-registered adviserCRD 307272
- Latest Form ADV
- 06/03/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +15.9% | +14.8% |
| Q1 2026 | +5.1% | -4.6% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Largest disclosed holdings
- Krystal Biotech Inc$16.7 million
- TG Therapeutics Inc$13.8 million
- Abivax SA SP ADS$12.9 million
- Chevron Corp New Com$12.4 million
- Exxon Mobil Corp.$10.7 million
- Arrowhead Pharmaceuticals In$9.0 million
- Viking Therapeutics Inc$8.2 million
- Celcuity Inc$6.5 million
- Nektar Therapeutics$6.2 million
- Tesla Mtrs Inc Com$4.5 million
As of 2026-06-30, from 13F filing by ACT Capital Management, LLC.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures